Identification and assessment of frailty in older patients with chronic myeloid leukemia and myelofibrosis, and indications for tyrosine kinase inhibitor treatment-Reference-Cited by-同舟云学术

Identification and assessment of frailty in older patients with chronic myeloid leukemia and myelofibrosis, and indications for tyrosine kinase inhibitor treatment

Published:2018-02-22 Issue:5 Volume:97 Page:745-754
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Breccia Massimo^ORCID,Palandri Francesca,Luciano Luigiana,Benevolo Giulia,Bonifacio Massimiliano,Caocci Giovanni,Castagnetti Fausto,Palumbo Giuseppe A.,Iurlo Alessandra,Landi Francesco

Funder

Novartis Italia

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/article/10.1007/s00277-018-3258-0/fulltext.html

Reference77 articles.

1. Kowal P, Dowd JE (2001) Definition of an older person. Proposed working definition of an older person in Africa for the MDS project. World Health Organization, Geneva. https://doi.org/10.13140/2.1.5188.9286

2. Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA (2009) Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 27(17):2758–2765. https://doi.org/10.1200/JCO.2008.20.8983

3. Price GL, Davis KL, Karve S, Pohl G, Walgren RA (2014) Survival pattern in United States (US) and medicare enrollees with non-CML myeloproliferative neoplasms (MPN). PLoS One 9(3):e90299. https://doi.org/10.1371/journal.pone.0090299